Taiwan · Delayed Price · Currency is TWD Intra-Cellular Therapies Statistics
Total Valuation
Vivotek has a market cap or net worth of TWD 8.12 billion. The enterprise value is 7.15 billion.
| Market Cap | 8.12B |
| Enterprise Value | 7.15B |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | Jul 30, 2025 |
Share Statistics
Vivotek has 86.57 million shares outstanding. The number of shares has increased by 0.72% in one year.
| Current Share Class | 86.57M |
| Shares Outstanding | 86.57M |
| Shares Change (YoY) | +0.72% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 3.33% |
| Owned by Institutions (%) | 4.22% |
| Float | 34.25M |
Valuation Ratios
The trailing PE ratio is 32.52.
| PE Ratio | 32.52 |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.35, with an EV/FCF ratio of -21.67.
| EV / Earnings | 28.31 |
| EV / Sales | 0.88 |
| EV / EBITDA | 15.35 |
| EV / EBIT | 23.48 |
| EV / FCF | -21.67 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.74 |
| Quick Ratio | 1.18 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 2.38 |
| Debt / FCF | -3.36 |
| Interest Coverage | 12.53 |
Financial Efficiency
Return on equity (ROE) is 8.11% and return on invested capital (ROIC) is 4.72%.
| Return on Equity (ROE) | 8.11% |
| Return on Assets (ROA) | 3.03% |
| Return on Invested Capital (ROIC) | 4.72% |
| Return on Capital Employed (ROCE) | 8.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.29 |
| Inventory Turnover | 3.81 |
Taxes
In the past 12 months, Vivotek has paid 65.27 million in taxes.
| Income Tax | 65.27M |
| Effective Tax Rate | 19.48% |
Stock Price Statistics
The stock price has decreased by -23.11% in the last 52 weeks. The beta is 0.76, so Vivotek's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -23.11% |
| 50-Day Moving Average | 106.57 |
| 200-Day Moving Average | 120.17 |
| Relative Strength Index (RSI) | 29.56 |
| Average Volume (20 Days) | 194,757 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vivotek had revenue of TWD 8.10 billion and earned 252.56 million in profits. Earnings per share was 2.88.
| Revenue | 8.10B |
| Gross Profit | 2.45B |
| Operating Income | 304.52M |
| Pretax Income | 335.01M |
| Net Income | 252.56M |
| EBITDA | 444.48M |
| EBIT | 304.52M |
| Earnings Per Share (EPS) | 2.88 |
Balance Sheet
The company has 2.14 billion in cash and 1.11 billion in debt, giving a net cash position of 1.03 billion or 11.92 per share.
| Cash & Cash Equivalents | 2.14B |
| Total Debt | 1.11B |
| Net Cash | 1.03B |
| Net Cash Per Share | 11.92 |
| Equity (Book Value) | 3.33B |
| Book Value Per Share | 37.62 |
| Working Capital | 2.17B |
Cash Flow
In the last 12 months, operating cash flow was -248.67 million and capital expenditures -81.22 million, giving a free cash flow of -329.89 million.
| Operating Cash Flow | -248.67M |
| Capital Expenditures | -81.22M |
| Free Cash Flow | -329.89M |
| FCF Per Share | -3.81 |
Margins
Gross margin is 30.30%, with operating and profit margins of 3.76% and 3.12%.
| Gross Margin | 30.30% |
| Operating Margin | 3.76% |
| Pretax Margin | 4.14% |
| Profit Margin | 3.12% |
| EBITDA Margin | 5.49% |
| EBIT Margin | 3.76% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.30, which amounts to a dividend yield of 2.45%.
| Dividend Per Share | 2.30 |
| Dividend Yield | 2.45% |
| Dividend Growth (YoY) | -39.47% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 130.25% |
| Buyback Yield | -0.72% |
| Shareholder Yield | 1.73% |
| Earnings Yield | 3.11% |
| FCF Yield | -4.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 13, 2019. It was a forward split with a ratio of 1.0249997438.
| Last Split Date | Aug 13, 2019 |
| Split Type | Forward |
| Split Ratio | 1.0249997438 |
Scores
Vivotek has an Altman Z-Score of 4.31 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.31 |
| Piotroski F-Score | 5 |